New era for management of chronic hepatitis C virus using direct antiviral agents: A review

Tamer Elbaz; Mohamed El-Kassas; Gamal Esmat

首页> 外文期刊>Journal of Advanced Research >New era for management of chronic hepatitis C virus using direct antiviral agents: A review

【24h】

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

机译：使用直接抗病毒药物治疗慢性丙型肝炎病毒的新时代：回顾

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The pegylated interferon regimen has long been the lone effective management of chronic hepatitis C with modest response. The first appearance of protease inhibitors included boceprevir and telaprevir. However, their efficacy was limited to genotype 1. Re

机译：长期以来，聚乙二醇化干扰素治疗一直是对中度慢性丙型肝炎的唯一有效治疗方法。蛋白酶抑制剂的首次出现包括boceprevir和telaprevir。但是，它们的功效仅限于基因型1。

著录项

来源
《Journal of Advanced Research》 |2015年第3期|共10页
作者
Tamer Elbaz; Mohamed El-Kassas; Gamal Esmat;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类生物科学;
关键词

相似文献

外文文献
中文文献
专利

1. Hepatitis B reactivation after interferon-based therapy versus pan-oral direct acting antiviral agents in chronic hepatitis C patients co-infected with hepatitis B virus: a systematic review and meta-analysis [J] . Wang Cheng, Li Bing, Chen Jing, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：基于干扰素的治疗后的乙型肝炎重新激活与慢性丙型肝炎患者患者慢性丙型肝炎病毒患者的泛骨直接作用抗病毒剂：系统审查和荟萃分析
2. Minimal Risk of Hepatitis B Virus Reactivation in Hepatitis B Virus Surface Antigen-Negative Chronic Hepatitis C Patients Receiving Direct Acting Antiviral Agents [J] . Liu Chen-Hua, Liu Chun-Jen, Su Tung-Hung, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：乙型肝炎病毒表面抗原阴性慢性丙型肝炎患者乙型肝炎病毒重新激活的最小风险，接受直接作用抗病毒药物
3. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection [J] . Chun-Jen Liu, Yu-Jen Fang, Tung-Hung Su, Open Forum Infectious Diseases . 2017,第1期

机译：接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
4. Genome-wide prediction and analysis of siRNA as potential antiviral agent against Hepatitis-C virus [C] . Divya Khanna, Vikas Kaushik, Atul Kumar Upadhyay International Conference on Bioinformatics and Systems Biology . 2018

机译：siRNA作为丙型肝炎病毒潜在抗病毒药物的全基因组预测和分析
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. New era for management of chronic hepatitis C virus using direct antiviral agents: A review [O] . Tamer Elbaz, Mohamed El-Kassas, Gamal Esmat 2015

机译：使用直接抗病毒剂治疗慢性丙型肝炎病毒的新时代：回顾
7. New era for management of chronic hepatitis C virus using direct antiviral agents: A review [O] . Tamer Elbaz, Mohamed El-Kassas, Gamal Esmat 2015

机译：利用直接抗病毒药物治疗慢性丙型肝炎病毒的新时代：综述
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

摘要

著录项

相似文献

相关主题

期刊订阅